Table 1.

Characteristics of the study cohorts of the validation studies

Study	Screening test	N	Stroke typea (n/n)	Age (year) (mean)	Male sex n (%)	Time since onset (days)
Al-Khawaja 1996 [13]	FAST	50	n.r.b	54	32 (64)	n.r.
Enderby 1987 [14]	FAST	50	n.r.	n.r.	n.r.	1–36
O’Neill 1990 [15]	FAST	54	n.r.	n.r.	n.r.	1
Flamand-Roze 2011 [21]	LAST	102	n.r.	62	52 (51)	n.r.
Choi 2015 [18]	MAST*	60	41/19	54	47 (78)	2–8
Kostalova 2008 [16]	MAST	194	n.r.	68–71c	97 (50)	1–46
Romero 2012 [17]	MAST	58	10/19	55	32 (55)	277d
Doesborgh 2003 [20]	ScreeLing	63	54/9	62	43 (68)	2–11
Al-Khawaja 1996 [13]	SST	50	n.r.b	54	32 (64)	n.r.
Kim 2011 [22]	SVF	53	27/n.r.	66	36 (68)	n.r.
Thommessen 1999 [19]	UAS	37	n.r.	76	15 (41)	3–8

FAST Frenchay Aphasia Screening Test, LAST Language Screening Test, MAST* Mobile Aphasia Screening Test, MAST Mississippi Aphasia Screening Test, SST Sheffield Screening Test for acquired language disorders, SVF semantic verbal fluency, UAS Ullevaal Aphasia Screening Test, n.r. not reported

^a n (ischemic stroke)/n (hemorrhagic stroke)

^b8 patients with traumatic brain injury were included in the study

^cMedian

^dMean